Bortezomib vs no bortezomib
Thrombocytopenia · All patients with a diagnosis of multiple myeloma
Bortezomib leads to higher adverse Events: Thrombocytopenia ‐ Bortezomib versus no bortezomib… compared with no bortezomib (high certainty).
1 finding from 1 review
- OR 1.51 [1.13, 2]3 studies · 1196 participantsHigh